Even after accounting for covariates, all levels of cannabis involvement remained significantly associated with SI, both less than a day (Odds-ratios [ORs] between 1.28 and 2.00, p < 0.05), and more than a day (ORs between 1.35 and 1.98, p < 0.01) compared to no SI (Table 3). A dose response relationship was observed such that those endorsing 3–6 CUD symptoms (O.R. 1.98–2.00) were most likely to report SI relative to those with fewer (O.R. 1.50–1.53) or no symptoms (O.R. 1.28–1.35).
